Forget Canopy Growth (TSX:WEED): Why This Other Company Might Dominate Cannabis Beverages

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be too busy to focus on the small beverages segment, and that could create an opportunity for another company to take advantage.

| More on:
The tops of soda cans

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED)(NYSE:CGC) sent shockwaves throughout the industry when it announced it had a deal with huge beverage maker Constellation Brands to work on cannabis beverages. And with Constellation increasing its investment in Canada’s top pot stock last year, it looked like the two companies might be a match made in heaven.

However, despite aligning itself with a popular producer of alcoholic drinks, we haven’t seen Canopy Growth come out with any big news relating to beverages. While it typically keeps its cards close to its vest, there’s another reason why the company might not be big in the beverages segment, and that’s because it has too many other things on the go.

Are beverages on the back burner?

With a big focus right now being on the U.S. market, by trying to tap into the hemp market and working a contingent deal with U.S.-based Acreage Holdings, beverages might actually be a low priority for the company today. Given the segment isn’t expected to be big out of the gate, there are certainly more lucrative options in the short term. That’s also why one of its rivals isn’t too concerned about beverages just yet.

Opportunity for another pot stock to shine

Instead, it might prove to be a smaller player jumping into the mix and dominating the scene. I’m talking about Hexo (TSX:HEXO), which has a beverage deal of its own with Molson Coors Canada. While it doesn’t involve a big investment like the Canopy-Constellation deal, nor is it as close of a partnership, it still gives both companies a jumpstart on their competition.

And while Hexo isn’t exactly standing pat either, it is certainly a bit more focused on the beverages segment than Canopy Growth appears to be. In a recent interview with BNN Bloomberg, the company’s CEO Sebastien St-Louis suggested that it would be ready for edibles with a “full suite of products” available sometime this year. In addition to beverages, it plans to have vape products and gummies as well.

It’s the first hint we’ve really seen that suggests there has been progress on the beverages front and that the company will have something ready to go. While that’s always been the assumption with companies that have partnered with big beverage makers, it’s not something we’ve seen confirmation of.

Coming up with a good formula that works with consumers and has been tested can be a long process, and so just because a deal is in place with a beer company doesn’t automatically mean that a successful cannabis product will be ready to go. However, in Hexo’s case, it certainly looks like things are going according to plan, and that could give it a big advantage when edibles get legalized in October of this year.

Bottom line

While Canopy Growth and other big industry players focus on other segments of the market, Hexo has an opportunity to stake out an early advantage in beverages and edibles, which will be important if it wants to be on track for the lofty goals it has set out for itself.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »